Compare Adaptive Biotechnologies Corp (ADPT) vs Paychex, Inc. (PAYX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Paychex, Inc. — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Paychex, Inc. trades at $120.92 (market cap $43.14B). The key difference: Paychex, Inc. is far larger — about 10.7× Adaptive Biotechnologies Corp's market cap, and Paychex, Inc. pays a 3.92% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | PAYX | |
|---|---|---|
Market Cap | $4.04B | $43.14B |
Sector | Health | Industrials |
52-Week High | $25.45 | $140.81 |
52-Week Low | $12.30 | $85.57 |
Enterprise Value | $4.10B | $46.63B |
Dividend Yield | — | 3.92% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Paychex, Inc.
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →
